Skip to content

About me
Research & Publications
Useful links

weighted-value

November 6, 2016 Return to: Brand Valuation of OTC Pharmaceutical BusinessesFull resolution (810 × 162)

Image navigation

Share this:

LinkedIn
Twitter
Facebook
Print
Tumblr

Like this:

Like Loading...

Dimitris uses its unique blend of studies in Management and Biotech combined with his quick witted entrepreneurial spirit to give small business owners in the Pharmaceutical industry, reliable advice and direction to make their businesses financially and strategically sustainable.

Search for:

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 126 other followers

Recent Posts

The Mathematics of Venture Capital Returns
Implantable biolectronics: The future of biomedicine?
Is the Celgene / Amgen deal for Otezla fair?
Biotech rNPV Valuation using Monte Carlo simulation – A simple approach
Is Novartis leading the way in pharma R&D restructuring?

Recent Comments

Isabelle on Can U.S. Drug Prices be Justif…

Categories

Finance
Strategy
Uncategorised

Archives

December 2019
October 2019
August 2019
November 2018
March 2017
December 2016
November 2016
October 2016
August 2016
November 2015
July 2015
December 2014
October 2014
July 2014
May 2014
April 2014
February 2014
January 2014
December 2013
November 2013
October 2013
August 2013
July 2013
June 2013
May 2013
March 2013
February 2013

AstraZeneca balance sheet items biotechnology current liabilities effective tax rate free cash flow free cash flow calculation patent expiry Pfizer valuation valuation methodologies value and risk

Blog Stats

129,676 hits

Blog at WordPress.com.

%d bloggers like this: